4Nakata K, Zhu YJ, Shin YS, et al. Symposium: diffuse panbronchiolitis in Asia.熊本，第38回日本呼吸器学会总会,1998：103-108．
5Yanagihara K, Kadoto J, Kohno S. Diffuse panbronchiolitis pahtophysiology and treatment mechanisms. Int J Antimicrob Agents, 2001,18 ( Suppl 1) : S83-87.
6Akai S, Okayama H, Shimura S, et al. Delta F508 mutation of cystic fibrosis gene is not found in chronic bronchitis with severe obstruction in Japan. Am Rev Respir Dis, 1992, 146 (3): 781-783.
8Kaneko Y,Yanagihara K, Seki M, et al. Clarithromycin inhibits overproduction of muc5ac core protein in murine model of diffuse panbronchiolitis. Am J Physiol Lung Cell Mol Physiol,2003,285 (4) : L847-853.
9Kamio K, Matsushita I, Hijikata M, et al. Promoter analysis and aberrant expression of MUCSB gene in diffuse panbronchiolitis.Am J Respir Crit Care Med,2005,171(9) :949-957.
10Boat TF,Cheng PW. Biochemistry of mucus:Airway secretion.Fed Proc, 1989,39 (13) : 3067-3074.
6Perrotta C, Oritz 2.-, Roque M. Chest physiotherapy for acutebronchiolitis in paediatric patients between 0 and 24months old[J]. Cochrane Database Syst Rev,2005 ,18(2) :CD004873.
7Joseph J. Zorc and Caroline Breese Hall. Bronchiolits: recentevidence on diagnosis and managemen[J]. Pediatrics,2010,125?2):342-345.
8Sheeran P, Jafri H,Carubelli C,et al. Elevated cytokineconcentrations in the asopharyngeal and tracheal secretions ofchildren with respiratory syncytial virus disease [J]. PediatrInfect Dis J,1999,18(2):115-122.
